| 11β-OH-3α,5α-THA | 11β-Hydroxyandrosterone |
| 11β-hydroxyandrostenedione | 11β-OH-A |
| 16α-OH-P | 16α-Hydroxyprogesterone |
| 16α-OH-Preg | 16α-Hydroxypregnenolone |
| 17-OH-P | 17-Hydroxyprogesterone |
| 17-OH-Preg | 17-Hydroxypregnenolone |
| 17-OH-20α-DHP | 17α-Hydroxy-20α-dihydroprogesterone |
| 5α-DHA | 5α-Androstane-3,17-dione |
| 5α-DHT | 5α-Dihydrotestosterone |
| 3α,5α,17-PD | 17-Hydroxyallopregnanolone |
| 3α,5α,17,20α-PT | 5α-Pregnane-3α,17,20α-triol |
| 3α,5α,20α-PD | 5α-Pregnane-3α, 20α-diol |
| 3α,5α-THA | Androsterone |
| 3α,5α-THP | 3α,5α-Tetrahydroprogesterone, allopregnanolone |
| 3β,5α,17,20α-PT | 5α-Pregnane-3β,17,20α-triol |
| 3β,5α-THA | Epiandrosterone |
| 3α,5β,17,20α-PT | 5β-Pregnane-3α,17,20α-triol |
| 3α,5β,17-PD | 17-Hydroxypregnanolone |
| 3α,5β-THA | Etiocholanolone |
| 3α,5β-THA | Epietiocholanolone |
| 8-iso-PGF2α | 8-iso-Prostaglandin F2α |
| σ1Rs | Sigma-1 receptors |
| A | Androstenedione |
| ACTH | Adrenocorticotropic hormone |
| AD | Androstanediol |
| ADIOL | Androstenediol |
| AKR1C1 | Aldo-keto reductase family 1 member C1 |
| AKR1C2 | Aldo-keto reductase family 1 member C2 |
| AKR1C3 | Aldo-keto reductase family 1 member C3 |
| AKR1D1 | 5β-Reductase |
| AMPARs | α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors |
| ANOVA | Analysis of variance |
| AT | Androstenetriol (5-androstene) |
| BBB | Blood-brain barrier |
| CI | Confidence interval |
| CNS | Central nervous system |
| CRH | Corticotropin-releasing hormone |
| CYP11A1 | Cholesterol desmolase |
| CYP11B1 | 11β-Hydroxylase |
| CYP17A1 | C17-hydroxylase-C17,20-lyase |
| CYP19A1 | Aromatase |
| CYP21A2 | 21-Hydroxylase |
| CYP3A4 | Cytochrome P450 3A4 |
| CYP3A7 | Cytochrome P450 3A7 |
| CYP7B1 | 7α-hydroxylase |
| DHEA | Dehydroepiandrosterone |
| DHEAS | Dehydroepiandrosterone sulfate |
| DHP | Dihydroprogesterone |
| EDSS | Expanded Disability Status Scale |
| ERα | Estrogen receptors α |
| ERβ | Estrogen receptors β |
| FSH | Follicle-stimulating hormone |
| GABA | γ-Aminobutyric acid |
| GABAARs | Type A γ-aminobutyric acid receptors |
| GR | Glucocorticoid receptors |
| GC-MS/MS | Gas chromatography tandem mass spectrometry |
| GPER | G protein-coupled estrogen receptors |
| HPAA | Hypothalamic-pituitary-adrenal axis |
| HSD3B1 | Type 1 3β-Hydroxysteroid dehydrogenase |
| HSD3B2 | Type 2 3β-Hydroxysteroid dehydrogenase |
| HSD3Bs | Type 1 and 2 3β-Hydroxysteroid dehydrogenases |
| HSD11B1 | Type 1 11β-Hydroxysteroid dehydrogenase |
| HSD11B2 | Type 2 11β-Hydroxysteroid dehydrogenase |
| HSD17B2 | Type 2 17β-Hydroxysteroid dehydrogenase |
| HSD17B3 | Type 3 17β-Hydroxysteroid dehydrogenase |
| HSD17B6 | Type 6 17β-Hydroxysteroid dehydrogenase (3α/β epimerase) |
| HPT9_R | 9-Hole Peg Test for right hand |
| HPT9_L | 9-Hole Peg Test for left hand |
| IFN-γ | Interferon γ |
| IL-1 | Interleukin 1 |
| IL-2 | Interleukin 2 |
| IL-4 | Interleukin 4 |
| IL-6 | Interleukin 6 |
| IL-10 | Interleukin 10 |
| IL-12 | Interleukin 12 |
| IL-17 | Interleukin 17 |
| LLR | Logarithm of likelihood ratio |
| mRNA | Messenger ribonucleic acid |
| NASs | Neuroactive steroids |
| NMDA | N-methyl-D-aspartate |
| NMDARs | N-methyl-D-aspartate receptors |
| OPLS | Orthogonal predictions to latent structure |
| P | Progesterone |
| PD | Pregnanediol |
| PGF2α | Prostaglandin F2α |
| PNS | Peripheral nervous system |
| Preg | Pregnenolone |
| PregS | Pregnenolone sulfate |
| PT | Pregnanetriol |
| ROS | Reactive oxygen species |
| SRD5A1 | Type 1 5α-reductase |
| SRD5A2 | Type 2 5α-reductase |
| SULT2A1 | Steroid sulfotransferase type 2A1 |
| STS | Steroid sulfatase |
| T | Testosterone |
| T25FWT | Timed 25-foot walk |
| THP | Tetrahydroprogesterone |
| TNF-α | Tumor necrosis factor α |
| TRPC5s | Short transient receptor potential channels 5 |
| TRPV1s | Vanilloid receptors |
| TRPM3s | Melastatin receptors |
| The letter C after the abbreviation of a steroid indicates its conjugated form | |
| The “, C” after the molar ratio of a steroid indicates that they are its conjugated forms. | |